Full View

Apixaban for the secondary prevention of thrombosis among patients with antiphospholipid syndrome: study rationale and design (ASTRO-APS)

SC Woller, SM Stevens, DA Kaplan… - Clinical and applied …, 2016 - journals.sagepub.com
Background: Antiphospholipid syndrome (APS) is an acquired thrombophilia characterized
by thrombosis, pregnancy morbidity, and the presence of characteristic antibodies. Current …
被引用次数：113 相关文章

Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS)

SC Woller, SM Stevens, DA Kaplan… - Clinical and Applied …, 2016 - hero.epa.gov
Antiphospholipid syndrome (APS) is an acquired thrombophilia characterized by
thrombosis, pregnancy morbidity, and the presence of characteristic antibodies. Current …

Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS)

SC Woller, SM Stevens, DA Kaplan, DW Branch… - 2016 - pubmed.ncbi.nlm.nih.gov
Background Antiphospholipid syndrome (APS) is an acquired thrombophilia characterized
by thrombosis, pregnancy morbidity, and the presence of characteristic antibodies. Current …

Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS).

SC Woller, SM Stevens, DA Kaplan… - Clinical and Applied …, 2015 - europepmc.org
Background Antiphospholipid syndrome (APS) is an acquired thrombophilia characterized
by thrombosis, pregnancy morbidity, and the presence of characteristic antibodies. Current …

Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome.

SC Woller, SM Stevens, DA Kaplan… - Clinical & Applied …, 2016 - search.ebscohost.com
Background: Antiphospholipid syndrome (APS) is an acquired thrombophilia characterized
by thrombosis, pregnancy morbidity, and the presence of characteristic antibodies. Current …